Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management

Erstveröffentlichung

2020

Authors

Saussele, Susanne

Haverkamp, Wilhelm

Lang, Fabian

Koschmieder, Steffen

Kiani, Alexander

et al.

Wissenschaftlicher Artikel

Published in

Acta haematologica ; 143 (2020), 3. - S. 217-231. - ISSN 0001-5792. - eISSN 1421-9662

Link to publication

https://dx.doi.org/10.1159/000501927

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: Chronic myeloid leukemia | Philadelphia chromosome-positive acute leukemia | Tyrosine kinase inhibitor | Ponatinib | Cardiovascular management | Consensus paper | ACUTE LYMPHOBLASTIC-LEUKEMIA | TYROSINE KINASE INHIBITORS | FOLLOW-UP | PHASE-II | BCR-ABL | IMATINIB RESISTANCE | COMPOUND MUTATIONS | MOLECULAR RESPONSE | DOMAIN MUTATIONS | EFFICACY
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record